Upon comparison with gene mutation subtypes, we found that CO and FR patients more closely resembled PHO patients with the SLCO2A1 mutation, whereas the characteristics of IN patients were aligned more with those of PHO patients with the HPGD mutation [5, 10, 11]. This evidence concerns the gene SLCO2A1 and primary hypertrophic osteoarthropathy.